tradmap

MANE Earnings Veradermics, Inc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$112 -$56 $0 2024 2025
EPS
Net income (annual)
-$70M -$35M $0 2024 2025
Net income
Return on equity (annual)
0% 29% 58% 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$24 -$12 $0 Q1 '25 Q2 '25 Q1 '26 Q2 '26
EPS
Net income (quarterly)
-$27M -$14M $0 Q1 '25 Q2 '25 Q1 '26 Q2 '26
Net income
Return on equity (quarterly)
-7% 7% 21% 0% Q1 '25 Q2 '25 Q1 '26 Q2 '26
ROE

Reported EPS history

1–6 of 6
Q2 20262026-06-30-0.582026-08-1110-Q
Q1 20262026-03-31-1.322026-05-1210-Q
FY 20252025-12-31-111.912026-03-3010-K
Q2 20252025-06-30-24.19——
Q1 20252025-03-31-19.79——
FY 20242024-12-31-37.05——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.